Department of Pathology and Cell Biology, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York.
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Mod Pathol. 2024 Nov;37(11):100596. doi: 10.1016/j.modpat.2024.100596. Epub 2024 Aug 20.
Spread through air spaces (STAS), an important prognostic indicator included in the 2015 World Health Organization classification, is defined as micropapillary, solid, and/or single tumor cell clusters beyond the edge of the main mass and distinct from processing artifacts. This study aimed to assess the interresponder agreement on current STAS criteria vs artifacts, identify discrepancies, and compare responses between pulmonary and general pathologists. A multiple-choice online questionnaire illustrating multiple criteria for STAS vs artifacts was available internationally for 6 days to Pulmonary Pathology Society members, thoracic pathology course attendees, and International Association for the Study of Lung Cancer pathology committee members. Additional 4 questions gathered demographic and practice setting information. One hundred thirty-six unique responses were analyzed. The majority were from North America and Europe (42.6% and 30.2%), practicing pulmonary pathology (70.6%) in academia (64.7%), and with >20 years of experience (31.6%). Excluding trainees, the greatest overall agreement was in defining solid and micropapillary tumor clusters of STAS located ≥3 alveolar spaces from the main tumor edge (91.5%) and recognizing strips of ciliated cells as artifacts (97.7%). Lesser agreement on STAS was evident when tumor cell clusters were immediately adjacent to the tumor edge, a single tumor cell cluster was present at the tissue edge, tumor cell clusters were jagged edged, or tumor cell clusters were admixed with ciliated cell strips (artifacts). There was no significant difference in agreements on STAS for multiple criteria between pulmonary and general pathologists. Significant interresponder agreement on STAS vs artifacts was achieved only for a few criteria. To improve the reproducibility of STAS vs artifacts, areas of lesser agreement require further clarification.
气腔内播散(STAS)是 2015 年世界卫生组织分类中的一个重要预后指标,定义为超出主肿瘤边缘的微乳头、实体和/或单个肿瘤细胞簇,且与处理伪影不同。本研究旨在评估当前 STAS 标准与伪影的应答者间一致性,识别差异,并比较肺病理学家和普通病理学家的反应。一项关于 STAS 与伪影的多项选择在线问卷,可供肺病理学会成员、胸病理课程参与者和国际肺癌研究协会病理委员会成员使用,为期 6 天。另外 4 个问题收集了人口统计学和实践环境信息。分析了 136 个独特的回复。大多数来自北美和欧洲(42.6%和 30.2%),在学术界从事肺病理学(64.7%),且经验超过 20 年(31.6%)。不包括学员,在定义位于主肿瘤边缘≥3 个肺泡空间的 STAS 实性和微乳头肿瘤簇以及识别纤毛细胞条带为伪影方面,总体一致性最大(91.5%和 97.7%)。当肿瘤细胞簇紧邻肿瘤边缘、单个肿瘤细胞簇位于组织边缘、肿瘤细胞簇呈锯齿状边缘或肿瘤细胞簇与纤毛细胞条带(伪影)混合时,对 STAS 的一致性就较小。肺病理学家和普通病理学家对多个 STAS 标准的一致性没有显著差异。只有少数几个标准在 STAS 与伪影之间达到了显著的应答者间一致性。为了提高 STAS 与伪影的重现性,需要进一步澄清一致性较小的领域。